NASDAQ:WHRT - WorldHeart Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market Capitalization$7.70 million
P/E RatioN/A
Dividend YieldN/A
World Heart Corporation (WorldHeart) is engaged in the development and sale of ventricular assist devices (VADs), particularly the Levacor Rotary VAD (Levacor VAD or Levacor). VADs are mechanical assist devices that supplement the circulatory function of the heart by re-routing blood flow through a mechanical pump allowing for the restoration of normal blood circulation. VADs are used for treatment of patients with severe heart failure, including patients whose hearts are irreversibly damaged and cannot be treated effectively by medical or surgical means other than transplant. Bridge-to-Transplant therapy (BTT) therapy involves implanting a VAD in a transplant-eligible patient to maintain or improve the patient's health until a donor heart becomes available. In August 2012, HeartWare International, Inc. acquired WorldHeart.

Receive WHRT News and Ratings via Email

Sign-up to receive the latest news and ratings for WHRT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A
Market Cap$7.70

WorldHeart (NASDAQ:WHRT) Frequently Asked Questions

What is WorldHeart's stock symbol?

WorldHeart trades on the NASDAQ under the ticker symbol "WHRT."

What is the consensus analysts' recommendation for WorldHeart?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for WorldHeart in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are WorldHeart's key executives?

WorldHeart's management team includes the folowing people:
  • Michael Sumner Estes Ph.D., Independent Chairman of the Board (Age 69)
  • Morgan R. Brown CPA, Interim Principal Executive Officer, Chief Financial Officer, Executive Vice President, Secretary (Age 47)
  • John Campbell Woodard Ph.D., Senior Vice President - Scientific Affairs (Age 56)
  • Jeani C. Delagardelle, Independent Director
  • William C. Garriock, Independent Director (Age 74)
  • Anders D. Hove M.D., Independent Director (Age 50)
  • Eugene B. Jones, Independent Director (Age 64)
  • Austin W. Marxe, Independent Director (Age 71)

Has WorldHeart been receiving favorable news coverage?

Media headlines about WHRT stock have trended somewhat positive recently, according to Accern Sentiment. The research group scores the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. WorldHeart earned a news impact score of 0.05 on Accern's scale. They also assigned press coverage about the healthcare company an impact score of 46.26 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of WorldHeart?

Shares of WHRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How big of a company is WorldHeart?

WorldHeart has a market capitalization of $7.70 million.

How can I contact WorldHeart?

WorldHeart's mailing address is 500 Old Connecticut Path, Ma, SALT LAKE CITY, UT 01701, United States. The healthcare company can be reached via phone at +1-508-7390864.

MarketBeat Community Rating for WorldHeart (NASDAQ WHRT)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  22 (Vote Outperform)
Underperform Votes:  28 (Vote Underperform)
Total Votes:  50
MarketBeat's community ratings are surveys of what our community members think about WorldHeart and other stocks. Vote "Outperform" if you believe WHRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WHRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/20/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.